William Blair & Company is acting as the lead book-running manager for the offering and Raymond James & Associates, Inc. is acting as joint book-running manager for the offering.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VKTX:
- Viking Therapeutics price target raised to $32 from $28 at Truist
- Viking Therapeutics price target raised to $19 from $15 at Roth MKM
- Viking Therapeutics price target raised to $25 from $15 at Maxim
- Viking Therapeutics price target raised to $35 from $12 at Raymond James
- Viking Therapeutics price target raised to $30 from $20 at Oppenheimer